---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-218896"
form_type: "8-K/A"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2022-08-12T23:59:59+00:00"
generated_at: "2026-06-24T00:36:04.717906+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# ResMed to acquire MediFox-Dan for EUR 810M; closing expected by Dec 31, 2022

## Summary
- Base purchase price of EUR 810M fixed via locked box; enterprise value EUR 950M.
- Funded with existing cash and borrowings under credit facility; intercompany loan to ResMed Germany SaaS.
- Closing subject to German merger control, foreign investment, and BaFin clearances.
- Termination fee of EUR 10M payable to seller if BaFin clearance not obtained.
- Acquisition of 100% of MediFox-Dan shares and shareholder loan receivables.

## SEC filing metadata
- accession: 0001193125-22-218896
- form_type: 8-K/A
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2022-08-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 8.01, 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312522218896/0001193125-22-218896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312522218896/d387047d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-218896
- JSON: https://secwatch.observer/filing/0001193125-22-218896.json
- Plain text: https://secwatch.observer/filing/0001193125-22-218896.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.